Tribute to Chinese Physician's Day

//

"In the early days of the development of heart disease, older generations of experts and scholars in our country paid a huge effort. As the inheritor, we gradually created China's advantage of structural heart disease intervention. In the future, the road of young doctors will be wider Through the efforts of generations, more effective professional integration with medical workers will be promoted to create more Chinese original technologies in the field of cardiovascular disease. "

Structural heart disease is the Asian specialty concept of cardiovascular fields proposed in 2006, mainly including congenital heart disease and valve disease. As early as 1994, Professor Zhang Gejun, who was admitted to the Study of the Peking Union Medical College, has begun work. At the same time, he was also the first Chinese doctor to be invited to the developed countries in North America.

He has been engaged in this field for 28 years. As a world -class expert, Professor Zhang Gejun, deputy director of the Structural Heart Disease Center of Fuwai Hospital of the Chinese Academy of Medical Sciences, can proudly say that in the field of heart disease in structural heart disease, Chinese doctors have made great contributions , A variety of technologies are at the forefront of the world; in the field of valve disease, "taking pulmonary valve as an example, even the surgery equipment has the Chinese invented." Zhang Gejun said that although we started in many ways, we rose up to catch up. , Improved related technologies, simplified surgical methods, and made it applicable to more patients, creating their own solutions and methods in this field.

"Based on China's national conditions and the onset of patients, we have summarized the experience of interventional therapy for structural heart disease. In the future, we will continue to change the traditional concepts and methods, and we will be committed to sharing diagnosis and treatment experience with international peers to create a structure. Chinese model of sex heart disease. "

Standing at the tide of the development of intervention therapy

In 1989, Zhang Gejun was admitted to Xi'an Medical University (now Xi'an Jiaotong University Medical College). Although his medicine was not Zhang Gejun's independent choice, since he came to the medical school, Zhang Gejun was at ease. During the postgraduate entrance examination, Zhang Gejun set the goal at the Concord Medicine College. "One is because of the fame of Xiehe, and the other is that there are very few PhDs at the time of medical schools at that time, and they can read it in Concord." Zhang Gejun said, "During the internship, The units who see a lot of papers are written by Fuwai Hospital, and Fuwai belongs to the Confucian system, so I chose it. In fact, I did not know that Fuwai was a cardiovascular disease hospital. "

Before the retest, the teacher of the Education Department asked Zhang Gejun if he was willing to adjust his professionalism. As a fresh graduate, Zhang Gejun has a limited understanding of Cardiology, but with his interest in cardiovascular disease, the young man and teacher who are in full swing said, "As long as you can do cardiovascular." The teacher of the Education Department smiled and turned him to the radiology department.

At that time, the director of the radiology department of Fuwai Hospital was Professor Dai Raping, and was the pioneer of the intervention therapy of structural heart disease in my country. Fuwai Hospital had the most advanced cardiovascular radiation machine in the country at that time, but compared to the digital image cardiovascular radiors that can be released at any time, the conditions for interventional treatment were too simple. "At that time, there was only one chance to observe the lesion of the lesion during the operation. If you want to watch it repeatedly, you need to wash out the film in the dark chamber, and then look back on the screenplay." Zhang Gejun recalled that every time you watch the film director, you will arrange it. Good personnel, each person is staring at one part, remembering the relationship between the characteristics of the lesion and the surrounding structure, the interventional treatment must be found to find the lesion positioning by memory.

"Conductive intervention therapy has begun to develop since the 1960s and 1970s. Until the mid -1990s, the success rate was still low and the risks were relatively large. Director Dai Raping saw the AMPLATZER blocking device that was just appeared at the time. It is very keenly aware that this instrument will greatly change the current status of congenital heart disease intervention therapy, and quickly introduce it to China. "Dr. Zhang Gejun joined the top cardiovascular disease intervention treatment team in China at the beginning of his career. , Also catching up with the trend of the development of console disease intervention therapy.

In September 1998, Zhang Gejun was assigned by Professor Dai Raping to bring his research report -the initial result of China's first series of "Research on the Invasion of Disperture Dispiration Invasion", spoke at the European Cardiovascular and Interventional Radiology Conference held in Italy. At that time, the involvement of the first heart disease belonged to the rapid development of new technologies, and the results of Zhang Gejun brought a new voice to foreign colleagues.

Intervention technology changes the concept of structural heart disease treatment

Structural heart disease refers to the abnormal structure of the heart and large blood vessels. Zhang Gejun emphasized that the traditional heart structure abnormalities can be corrected by surgical. In 2006, Professor Horsst Sievert, a German doctor, proposed that the disease of heart structure abnormalities was similar to the method and concept of interventional treatment, so the first heart disease and valve disease were referred to as structural heart disease. After the concept of structural heart disease was proposed, the first focus of development was the treatment of console. With the development of valve disease intervention therapy and the rise of left -hearted ear sealing, the intervention therapy of valve disease has become a hot spot for current development and further enriches the content of the field.

However, before this concept was defined, Zhang Gejun had been undergoing intervention therapy for congenital heart disease under the guidance of his predecessors. It was the first participant in this field. The intervention therapy of structural heart disease has great dependence on imaging. "According to Professor Dai Raping, radiologists can see 256 gray levels between this black and white. More accurate, you can "refer to where to fight". "Zhang Gejun said.

Surgical surgery is an effective way to correct complex congenital heart disease, but patients after correction may also face different problems at different ages. Zhang Gejun saw such a case when he checked the literature. A 40 -year -old Fulo Four -Division patient, due to the repeated illness, performed 9 breast opening surgery throughout his life. "The first appearance of the manual valve replacement technology of the messenger of mankind -the emergence of the pelvic valve replacement (TPVR) of the pipeline of the pipeline is to solve the dilemma of opening the chest multiple times for such patients." Zhang Gejun said. TPVR was first applied to the clinic in Europe in 2000 in 2000, but European and American countries mainly developed balloon expansion valve in the early days, for patients with artificial pipelines, and this kind of equipment can only cover 20%of the Fulo Four Union in China. Patients after symptoms, so doctors and engineers have to find ways to develop TPVR equipment applicable to Chinese patients. "my country is one of the first countries in the world to carry out the clinical research of self -expansion TPVR equipment. There are many patients, and the results of clinical research are also good, and they have quickly received the attention of their peers." Zhang Gejun said. Subsequently, China's pulmonary valve intervention instrument began to conduct clinical research in Europe, and the EU's CE certification requires that some cases should be completed outside Europe to prove the universality of the product. From 2018 to 2019, Zhang Gejun promoted this technology to Canada in North America. At that time, Professor Miro, Canada sighed to Zhang Gejun. When he was in his 30s, he went to China to help the intervention treatment of room interval defects. Twenty years have passed. Now that the Chinese can teach technology in Canada, lamenting that the development of Chinese medical technology and equipment is fast. Essence

In addition to pulmonary valve replacement, currently the TAVR technology is very hot in the field of valve disease, that is, the aortic valve replacement surgery of the catheter, which is the second technology to be held by humans. In 2002, a French doctor completed the world's first TAVR surgery. It was a middle -aged and elderly person with complications such as heart -derived shock, and China's first TAVR surgery was completed in 2010. 2022 is the 20th anniversary of the birth of TAVR. With the advantages of small wounds, low risks, and fast recovery, it provides a safe and high -quality treatment method for patients with high risk of surgery or contraindications. In recent years, TAVR has developed very rapidly in the field of heart valve. In developed countries such as the United States, the application of TAVR surgery has surpassed the traditional chest opening surgery. In China, TAVR has also successfully implemented more than 10,000 cases, involving more than 30 provinces city.

"Cardiac valve disease has two methods: drug treatment and surgical therapy, but drug treatment cannot reverse this structural damage, so it can generally only be cured by surgery. With the aging of the domestic population, degenerate cardiac valve disease is ill, The number of people is constantly rising. Such patients are often older and may not be able to withstand traditional chest opening surgery. Tavr's minimally invasive surgery solves this problem. "Zhang Gejun said that compared with Western countries, my country's two -leaf petal deformity is deformed in China. High -round, and the new Tavr balloon expansion valve technology can successfully overcome this problem. "At present, the TAVR balloon expansion valve is mainly imported products. Many companies in my country are developing new TAVR devices."

The future of structural heart disease

Depending on originality and integration

China's contribution to the field of structural heart disease in the world benefits from the "post -first arrival" of Chinese doctors, and the technically flexible improvement of ideas. On the other hand, the level of structural heart disease in my country is high. huge amount of. "Conductive disease, rheumatism heart valve disease is related to economic backwardness." Zhang Gejun introduced that in areas with relatively poor economic conditions, the masses' health awareness is lacking, and patients and valve disease cannot be treated in a timely manner.

In order to shorten this gap, Zhang Gejun was sent to Fuwai Cardiovascular Vascular Disease Hospital in Yunnan Province as a structural heart disease expert. The Fuwai Cardiovascular Hospital of Yunnan Province was established in 2017 and is a pilot unit output and sinking for the National Medical Center. As the first batch of experts, in order to ensure the continuity of the construction of this new discipline, Zhang Gejun has been regularly went to the guidance work. One month is the fifth year of Zhang Gejun to work in Fuwai Cardiovascular Vascular Hospital in Yunnan Province.

Yunnan's economy is relatively backward. "Medical medicine in large cities like Beijing is more considered how to cure patients, but in Yunnan, not only should we consider cure patients, but also to save money for patients." Zhang Gejun said, Zhang Gejun said, saying that When I came to Yunnan, I found that many patients could not be treated in a timely manner because of economic reasons. "When I came here, I first knew the word" establishing a file ". It is also a baptism for your own mind. "

As far as the heart disease is concerned, the Fuwai Cardiovascular Vascular Disease Hospital in Yunnan Province completed 600 interventional treatment in the first year, and soon 800 cases were achieved. Now 1,000 cases can be completed each year, ranking among the top ten in the country. New technologies of valve disease intervention are also rooted here. Fuwai Cardiovascular Vascular Disease Hospital in Yunnan Province has become the most hospitalized hospitals in the province to complete the mount valve replacement and repair technology in the province.

"Looking back at the development history of structural heart disease intervention therapy, many equipment was invented by foreign countries. The reason is that in addition to the development of basic research such as foreign materials and biological sciences earlier and more complete, the combination of medical workers is better. Important reason, "Zhang Gejun said. Structural heart disease is a cross discipline. The structural heart disease center of Fuwai Hospital has doctors from various majors such as internal medicine, surgery, radiology, and ultrasound. Emphasizing the combination of medical workers and the transformation of results, and adhering to innovation -driven, we can get out of the development of structural heart disease with Chinese characteristics. not

On August 19, 2022, the fifth Chinese Physician's Day arrived as expected. The theme of this year's festival is "‘ medical ’heart and forge ahead!

not

In order to further promote the implementation of the relevant work of health China, the Health China Action Promotion Committee has formulated the "Key Points for the Work of Healthy China 2022", and proposed that hospitals and medical workers as the main position and main army of medical care must play a good demonstration role -do it Go to "Healthy Chinese Medical Doctors". The Health China Action Promotion Committee, the National Health and Health Commission, the Ministry of Education, and the Ministry of Transport and other 13 departments jointly issued the "Notice on Carrying out the" Caring for Life Salvation "activity" and advocating the "Caring for Life Salvation" activity, speeding up to speed up Promote the high -quality development of the masses.

not

As a result, under the guidance of the Office of the Health China Action Promotion Committee, the Medical News Agency and China Medical and Health Culture Association, China Medical and Health Development Foundation, China Health Promotion and Education Association, when the Fifth China Medical Day is coming, linkage North, Shang, Guang, Hangzhou-four cities subway, carry out the theme public welfare tour of the theme of "Healthy China and I Caring for Life 'Save".

Wonderful review of public welfare tour exhibition:

8 special lines in the north, Guangzhou -Hangzhou 4 places have been launched! The train will be equipped with 22 academicians including Academician Zhong Nanshan/Master of Chinese Medicine/National Medical Medicine, 145 Hospital Management Experts, and 1,582 medical elites of 1,220 public welfare tour posters. Passengers "intimate contact"! At the same time, the general poster video will cover 13,000 TVs on the subway and platforms on the 1st, 5th, 5th, 8th, 13th and Batong lines in Beijing, and the platform will be played many times a day. It is expected that the number of viewing will exceed 100 million!

Wonderful review of public welfare tour exhibition:

Wonderful article Review:

Tribute to Chinese Physician's Day · Healthy China, you and me, Professor Cui Chaobo: Shuli He's heart, clinical, scientific research, and teaching must not be less

Tribute to Chinese Physician Day · Health China You and I.

Tribute to Chinese Physician's Day

Tribute to Chinese Physician's Day

Tribute to Chinese Physician's Day

Capture: Jia Weiwei

Edit: Jia Weiwei

- END -